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The Local CNP/GC-B system in 
growth plate is responsible for 
physiological endochondral bone 
growth
Kazumasa Nakao1, Kenji Osawa1, Akihiro Yasoda2, Shigeki Yamanaka1, Toshihito Fujii2, 
Eri Kondo2, Noriaki Koyama1, Naotetsu Kanamoto2, Masako Miura2, Koichiro Kuwahara3, 
Haruhiko Akiyama4, Kazuhisa Bessho1 & Kazuwa Nakao5
Recent studies revealed C-type natriuretic peptide (CNP) and its receptor, guanylyl cyclase-B (GC-
B) are potent stimulators of endochondral bone growth. As they exist ubiquitously in body, we 
investigated the physiological role of the local CNP/GC-B in the growth plate on bone growth 
using cartilage-specific knockout mice. Bones were severely shorter in cartilage-specific CNP or 
GC-B knockout mice and the extent was almost the same as that in respective systemic knockout 
mice. Cartilage-specific GC-B knockout mice were shorter than cartilage-specific CNP knockout 
mice. Hypertrophic chondrocyte layer of the growth plate was drastically reduced and proliferative 
chondrocyte layer, along with the proliferation of chondrocytes there, was moderately reduced in 
either cartilage-specific knockout mice. The survival rate of cartilage-specific CNP knockout mice 
was comparable to that of systemic CNP knockout mice. The local CNP/GC-B system in growth plate 
is responsible for physiological endochondral bone growth and might further affect mortality via 
unknown mechanisms.
The natriuretic peptide family consists of three structurally related endogenous ligands: atrial natriu-
retic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP)1. The three 
natriuretic peptide receptors are membrane-bound proteins, two of which are biologically active guanylyl 
cyclase (GC)-coupled receptors (GC-A and GC-B), and one of which is a biologically silent metabolic 
clearance receptor (C-receptor)2. ANP and BNP, which exert their biological activities through GC-A3, 
are cardiac hormones produced predominantly in the atrium and ventricle of the heart, respectively1; 
these hormones are implicated in the regulation of blood pressure, water, and electrolyte balance4. On the 
other hand, CNP exerts its biological activities through GC-B, and is present in various tissues including 
brain, pituitary, blood vessels, ovary, testis, and cartilage5–18.
Most bones in mammals, including vertebrae and the long bones of limbs, are formed through endo-
chondral ossification, which involves the conversion of an initial cartilage template into bone via prolif-
eration, hypertrophy, cell death, and osteoblastic replacement in the growth plate. In previous studies, we 
and another group showed that mice systemically depleted of CNP or GC-B exhibit severely impaired 
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growth of vertebrae and long bones16,17. Given that both CNP and GC-B are expressed in the growth 
plate cartilage of vertebrae and long bones16, it is possible that the local CNP/GC-B system in the growth 
plate contributes in some way to physiological endochondral bone growth. However, the relevance of 
the contribution to physiological bone growth by CNP, either in the growth plate or originating in other 
tissues, is still elusive; direct or indirect effects of CNP from various tissues other than cartilage, including 
brain that is regarded to contain the most abundant CNP in body and pituitary, the center of the growth 
hormone-insulin like growth factor-I (GH/IGF-I) axis that regulates endochondral bone growth19, might 
play any roles on physiological endochondral bone growth. Actually, we developed transgenic mice with 
an elevated plasma concentration of CNP under the control of human serum amyloid P component pro-
moter and exhibited that these mice showed prominent skeletal overgrowth phenotype, indicating that 
CNP can humorally affect endochondral bone growth20. Furthermore, precise manners of the stimulation 
of endochondral ossification of the CNP/GC-B system in the growth plate are still elusive. Therefore, 
in the present study, we generated cartilage-specific CNP knockout mice using the Cre recombinase 
(Cre)-loxP system, which enables targeted depletion of an intended gene, and used these mice to inves-
tigate the physiological effects of CNP on endochondral bone growth in the growth plate. Furthermore, 
we knocked down GC-B in the growth plate in mice using the same Cre-loxP system, and further inves-
tigated the physiological roles of the CNP/GC-B system on endochondral bone growth there.
Results
Generation and gross phenotypes of mice with cartilage-specific deletion of CNP. In order 
to inactivate the murine CNP gene (Nppc) in the chondrogenic cell lineage, we used mice carrying 
Nppcflox, a Nppc allele in which the DNA segment that includes the 3’ part of exon 1 and all of exon 2 
is flanked by loxP sites; the floxed portions of the exons encode the entire structure of CNP (Fig.  1a). 
Figure 1. Generation and gross appearance of Col2a1-Cre; Nppcflox/flox mice. (a) Conditional targeting of 
Nppc. Restriction enzymes: E, EcoRI; Arrows: PCR primers. Triangles (black): loxP sites. Triangles (white): 
FRT sites. (b) RT-PCR analysis of Nppc in cartilage and brain of Col2a1-Cre; Nppcflox/flox and Nppcflox/flox mice. 
The full-length gel is presented in Supplementary Figure S1. (c) Quantitative real-time RT-PCR analysis for 
CNP expression in Nppcflox/flox and Col2a1-Cre; Nppcflox/flox mice. (d) Immunohistochemical analysis of CNP 
in growth plates of Nppcflox/flox and Col2a1-Cre; Nppcflox/flox mice. (e) Gross appearance of Nppcflox/flox (upper) 
and Col2a1-Cre; Nppcflox/flox (lower) mice. (f) Growth curves of naso-tail lengths of Nppcflox/flox (■) and  
Col2a1-Cre; Nppcflox/flox (□ ) mice. *: P < 0.01.
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Both heterozygous and homozygous mice carrying Nppcflox were viable and fertile, and they exhibited no 
noticeable phenotypic changes. We crossed mice heterozygous for the Nppcflox allele with mice heterozy-
gous for the Col2a1–Cre transgene, which enables targeted expression of the Cre recombinase in carti-
lage21. Offspring that inherited both the Nppcflox allele and the Col2a1–Cre transgene were mated with 
mice inheriting only the Nppcflox allele, in order to yield homozygous Nppcflox mice expressing Cre recom-
binase specifically in cartilage (Col2a1–Cre; Nppcflox/flox). Cartilage-specific deletion of CNP expression 
in the resultant Col2a1–Cre; Nppcflox/flox mouse was confirmed by RT-PCR (Fig.  1b and Supplementary 
Fig. S1). Quantitative real-time RT-PCR analyses revealed that the expression of CNP was dramatically 
decreased in the cartilage of Col2a1–Cre; Nppcflox/flox mouse compared to that of Nppcflox/flox mouse as the 
control (Fig. 1c). The decrease of CNP protein in the growth plate of Col2a1–Cre; Nppcflox/flox mouse was 
exhibited by the immunohistochemical staining using anti-CNP antibody (Fig. 1d).
Figure  1e depicts the gross appearance of a Col2a1–Cre; Nppcflox/flox mouse compared to that of an 
Nppcflox/flox mouse at the age of 10 weeks. At this age, the Col2a1–Cre; Nppcflox/flox mouse was shorter 
than the Nppcflox/flox mouse. The growth curves reveal that at the first week after birth, the Col2a1–Cre; 
Nppcflox/flox mice were only slightly smaller than the Nppcflox/flox mice; naso-anal and naso-tail lengths of 
Col2a1–Cre; Nppcflox/flox mice were 92.0% and 93.6%, respectively, of the corresponding lengths in the 
controls (Fig.  1f and Supplementary Fig. S2). Later, the growth of Col2a1–Cre; Nppcflox/flox mice was 
greatly retarded relative to controls: at the age of 6 weeks, naso-anal and naso-tail lengths of Col2a1–Cre; 
Nppcflox/flox mice were 78.6% and 77.6%, respectively, of the control lengths. After 6 weeks, Col2a1–Cre; 
Nppcflox/flox mice grew similarly to control mice, and at 10 weeks the naso-anal and naso-tail lengths of 
Col2a1–Cre; Nppcflox/flox mice were 78.6% and 75.6%, respectively, of the control lengths (Fig.  1f and 
Supplementary Fig. S2).
Skeletal phenotypes of cartilage-specific CNP knockout mice. Soft x-ray pictures revealed that 
the skeletal growth of Col2a1–Cre; Nppcflox/flox mice was severely impaired (Fig.  2a). At 10 weeks, the 
lengths of all bones formed through endochondral ossification were significantly shorter in Col2a1–Cre; 
Nppcflox/flox mice than in control mice: the lengths of humerus, radius, ulna, femur, tibia, and lumbar spine 
in Col2a1–Cre; Nppcflox/flox mice were 75.2, 68.6, 68.1, 65.5, 65.9, and 72.3%, respectively, of the control 
lengths (Fig. 2b). The length of the skull, which is primarily defined by endochondral bone growth, was 
significantly shorter in Col2a1–Cre; Nppcflox/flox mice at 86.5% of the control length. On the other hand, 
the width of the skull, which is defined by membranous ossification, did not differ between Col2a1–Cre; 
Nppcflox/flox and control mice (Fig. 2b).
In order to further characterize the impaired growth of bones formed through endochondral ossifica-
tion in cartilage-specific CNP knockout mice, we performed histological analyses of their growth plates. 
Histological images of the growth plate cartilage of proximal tibiae stained with Alcian Blue-hematoxylin 
and eosin revealed that at 2 weeks, the growth plates of Col2a1–Cre; Nppcflox/flox mice were obviously and 
significantly thinner than those of control mice (Fig.  2c). As shown by immunohistochemical staining 
for type II collagen, which is a marker for the non-hypertrophic chondrocyte layer, the thickness of the 
non-hypertrophic chondrocyte layer in Col2a1–Cre; Nppcflox/flox growth plates was 76.7% of the thickness 
in controls (Fig.  2d). Likewise, the extracellular spaces of the non-hypertrophic chondrocyte layer in 
Col2a1–Cre; Nppcflox/flox growth plates were greatly decreased compared to those of control growth plates 
(Fig. 2d). Moreover, immunohistochemical staining for type X collagen, which is specifically expressed in 
the hypertrophic chondrocyte layer of the growth plate, revealed that the thickness of the hypertrophic 
chondrocyte layer in Col2a1–Cre; Nppcflox/flox growth plates was drastically and significantly reduced, 
to 34.6% of the control thickness (Fig.  2e). The number and the size of hypertrophic chondrocytes in 
Col2a1–Cre; Nppcflox/flox growth plates were dramatically decreased compared to those in the control 
growth plates.
To investigate the decreased thickness of the proliferative chondrocyte layer of Col2a1–Cre; Nppcflox/flox  
growth plates, we examined the proliferation of chondrocytes in this region by immunohistochemical 
staining for 5-bromo-2′ -deoxy-uridine (BrdU) incorporation. The ratio of BrdU-positive chondrocytes 
tended to be lower in Col2a1–Cre; Nppcflox/flox growth plates relative to control (Fig.  2f). To investigate 
the decreased thickness of the hypertrophic chondrocyte layer, we monitored apoptosis by terminal 
deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining. However, this assay 
revealed almost no difference in the extent of chondrocyte apoptosis between Col2a1–Cre; Nppcflox/flox and 
control growth plates (Supplementary Fig. S3). Further we performed in situ hybridization analyses of 
differentiation markers of growth plate chondrocytes including type II and X collagens, Indian hedgehog 
and Sox9 (Fig. 3). We found the decreased areas expressing these differentiation markers in Col2a1–Cre; 
Nppcflox/flox growth plates compared with those in control growth plates. Moreover, the intensities of 
these gene expressions, especially that of Indian hedgehog, tended to be lower in Col2a1–Cre; Nppcflox/flox 
growth plates than in control growth plates.
Effects of skeletal abnormalities on mortality of Col2a1–Cre; Nppcflox/flox mice. Previously, we 
reported that more than half of systemic CNP knockout mice die before adulthood16. A considerable 
proportion of total CNP knockout mice exhibit severe malocclusion, which may prevent normal eat-
ing (Fig. 4a); Col2a1–Cre; Nppcflox/flox mice also exhibit this phenotype. In order to avoid starvation, we 
provided pulverized feed to total CNP knockout mice, and succeeded in increasing the survival rate 
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Figure 2. Impaired skeletal growth in Col2a1-Cre; Nppcflox/flox mice. (a) Soft x-ray picture and (b) 
morphometric analyses of bones (skull length, skull width, humerus, radius, ulna, femur, tibia, and lumber) 
of Nppcflox/flox and Col2a1-Cre; Nppcflox/flox mice at the age of 10 weeks. *: P < 0.01, n = 5, each. (c)–(f) 
Histological analyses of tibial growth plates of Nppcflox/flox and Col2a1-Cre; Nppcflox/flox mice at the age of 2 
weeks. Scale bar: 100 μ m in each panel. (c) Micrographs of growth plates stained by Alcian Blue-hematoxylin 
and eosin (left pictures), and the thickness of growth plates (right graph). *: P < 0.01, n = 5, each. In 
micrographs, right panel in each set of panels is exhibited with higher magnification. (d), (e) Micrographs of 
tibial growth plates stained by type II (d) and X (e) collagen antibodies (upper pictures), and the thickness 
of nonhypertrophic (d) and hypertrophic (e) chondrocyte layers of the growth plates (lower graphs). *: 
P < 0.01, n = 5, each. (f) Micrographs of tibial growth plates with BrdU labeling (left pictures) and the 
proliferative rate of chondrocytes in growth plate shown as the average percent of BrdU-positive cells relative 
to total cell count (right graph).
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(70% on pulverized feed vs. 40% on solid feed) (Fig. 4b). Subsequently, we provided pulverized feed to 
Col2a1–Cre; Nppcflox/flox mice and examined the effect on survival rates. As shown by the Kaplan-Meier 
graphs depicted in Fig. 4c, the 10-week survival rates of Col2a1–Cre; Nppcflox/flox mice were 75.0%.
Generation and gross phenotypes of cartilage-specific GC-B knockout mice. We had previ-
ously reported that CNP and GC-B are expressed in nonhypertrophic and prehypertrophic chondrocyte 
layers of the growth plate, respectively16, i.e., GC-B exists in close proximity to CNP in the growth plate. 
This suggests a local regulation of endochondral bone growth in growth plate by the CNP/GC-B system. 
Therefore, likewise we performed targeted depletion of GC-B in murine cartilage using the Cre-loxP 
Figure 3. In situ hybridization analyses of the Col2a1-Cre; Nppcflox/flox growth plate. In situ hybridization 
analyses for chondrocyte differentiation markers in the growth plates of Nppcflox/flox and Col2a1-Cre; Nppcflox/flox 
mice. HE; hematoxylin and eosin, Ihh; Indian hedgehog.
Figure 4. Effect of the skeletal abnormality in CNP mutant mice on mortality. (a) Left set of pictures: 
gross morphologies of 12-week-old total CNP knockout mice with severe malocclusion (left) and normal 
occlusion (right) of the incisal teeth. Right: three-dimensional reconstructed image of a 12-week-old Nppc−/− 
mouse with severe malocclusion. (b) Survival curves of total CNP knockout mice supplied with solid feed 
() and pulverized feed (Δ ). (c) Survival curves of Nppcflox/flox (◆) and Col2a1-Cre; Nppcflox/flox (◊) mice.
www.nature.com/scientificreports/
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system, and further elucidated and confirmed the physiological effects of the local CNP/GC-B system in 
the growth plate on endochondral bone growth. Likewise, we generated mice carrying Npr2flox, an Npr2 
allele in which the DNA segment including exons 3–7 is flanked by loxP sites; exons 3–7 encode the 
C-terminal half of the extracellular ligand-binding domain and the transmembrane segment17 (Fig. 5a). 
Both heterozygous and homozygous mice carrying Npr2flox were viable and fertile, and they exhibited 
no noticeable phenotypic change. Cartilage-specific Npr2-deleted mice (Col2a1–Cre; Npr2flox/flox) were 
generated by a breeding scheme similar to the one described above, in this case using heterozygous 
Npr2flox and Col2a1–Cre transgenic mice. Cartilage-specific deletion of GC-B expression in Col2a1–Cre; 
Nppcflox/flox mouse was confirmed by RT-PCR (Fig. 5b and Supplementary Fig. S4). Quantitative real-time 
RT-PCR analyses revealed that the expression of GC-B gene was almost completely depleted in the 
cartilage of Col2a1–Cre; Npr2flox/flox mouse (Fig. 5c). The decrease of GC-B protein in the growth plate 
of Col2a1–Cre; Npr2flox/flox mouse was exhibited by the immunohistochemical staining using anti-GC-B 
antibody (Fig. 5d).
We obtained qualitatively similar results from the cartilage-specific GC-B knockout (Col2a1–Cre; 
Npr2flox/flox) mice. At 10 weeks, Col2a1–Cre; Npr2flox/flox mice were obviously shorter than Npr2flox/flox mice 
(Fig. 5e). As shown by the growth curve, Col2a1–Cre; Npr2flox/flox mice were slightly smaller than Npr2flox/flox  
mice at 1 week; naso-anal and naso-tail lengths of Col2a1–Cre; Npr2flox/flox mice were 90.7% and 89.3%, 
respectively, of the corresponding lengths in control mice (Fig. 5f and Supplementary Fig. S5). Later, the 
growth of Col2a1–Cre; Npr2flox/flox mice was greatly retarded relative to controls: at 6 weeks, naso-anal 
and naso-tail lengths of Col2a1–Cre; Npr2flox/flox mice were 73.8% and 62.1%, respectively, of the control 
lengths. After 6 weeks, Col2a1–Cre; Npr2flox/flox mice grew similarly to the control mice, and at 10 weeks, 
the naso-anal and naso-tail lengths of Col2a1–Cre; Npr2flox/flox mice were 72.5% and 63.1%, respectively, 
of the control lengths (Fig. 5f and Supplementary Fig. S5).
Figure 5. Generation and gross phenotype of Col2a1-Cre; Npr2flox/flox mice. (a) Conditional targeting 
of Npr2. Restriction enzymes: E, EcoRI; S, SacI; V, EcoRV; Arrows: PCR primers. Triangles (black): loxP 
sites. Triangles (white): FRT sites. (b) RT-PCR analysis of Npr2 gene in cartilage and brain of Col2a1-Cre; 
Npr2flox/flox and Npr2flox/flox mice. The full-length gel is presented in Supplementary Figure S4. (c) Quantitative 
real-time RT-PCR analysis for GC-B expression in Npr2flox/flox and Col2a1-Cre; Npr2flox/flox mice. (d) 
Immunohistochemical analysis of GC-B in growth plates of Npr2flox/flox and Col2a1-Cre; Npr2flox/flox mice. (e) 
Gross appearance of Npr2flox/flox (upper) and Col2a1-Cre; Npr2flox/flox (lower) mice. (f) Growth curves of naso-
tail length of Npr2flox/flox (■) and Col2a1-Cre; Npr2flox/flox (□ ) mice. *: P < 0.01.
www.nature.com/scientificreports/
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Skeletal phenotypes of cartilage-specific GC-B knockout mice. As shown by soft x-ray pictures 
of mice at the age of 10 weeks, skeletal growth was severely impaired in Col2a1–Cre; Npr2flox/flox mice 
(Fig. 6a). The lengths of humerus, radius, ulna, femur, tibia, and lumbar spine in Col2a1–Cre; Npr2flox/flox 
mice were 62.4, 61.3, 60.0, 45.3, 54.6, and 68.2%, respectively, of their lengths in control mice (Fig. 6b). 
The length of the skull was significantly shorter in Col2a1–Cre; Npr2flox/flox, at 81.0% of the control length, 
but the width of the skull did not differ between Col2a1–Cre; Npr2flox/flox and control mice (Fig.  6b). 
In addition, Col2a1–Cre; Npr2flox/flox mice also exhibited malocclusion just as observed in systemic or 
cartilage-specific CNP knockout mice.
Further we performed histological analyses of the growth plates of cartilage-specific GC-B knockout 
mice. As in the case of Col2a1–Cre; Nppcflox/flox mice, the growth-plate cartilage of the proximal tibiae 
in Col2a1–Cre; Npr2flox/flox mice was obviously and significantly thinner than in control mice (Fig.  6c). 
Immunohistochemical staining for type II collagen revealed that the thickness of the non-hypertrophic 
chondrocyte layer in Col2a1–Cre; Npr2flox/flox growth plates was 71.1% of the thickness in controls 
(Fig. 6d). The extracellular spaces of the non-hypertrophic chondrocyte layer in Col2a1–Cre; Npr2flox/flox  
growth plates were greatly decreased compared to those of controls (Fig.  6d). Immunohistochemical 
staining for type X collagen revealed that the thickness of the hypertrophic chondrocyte layer in Col2a1–
Cre; Npr2flox/flox growth plates was severely decreased, to 23.0% of the control thickness (Fig.  6e). The 
number and the size of hypertrophic chondrocytes in Col2a1–Cre; Npr2flox/flox growth plates were greatly 
decreased compared to those in the control growth plates. Immunohistochemical staining for BrdU 
incorporation of the proliferative chondrocyte layer of Col2a1–Cre; Npr2flox/flox growth plates revealed that 
the ratio of BrdU-positive chondrocytes was significantly lower in Col2a1–Cre; Npr2flox/flox growth plates 
relative to control (Fig.  6f). As in the case of Col2a1–Cre; Nppcflox/flox mice, TUNEL staining revealed 
almost no difference in the extent of chondrocyte apoptosis between Col2a1–Cre; Npr2flox/flox and control 
growth plates (Supplementary Fig. S6).
Discussion
The CNP/GC-B system is present in a wide variety of tissues and has been assumed to play roles as a 
local regulator22. CNP was first isolated from porcine brain23 and is distributed throughout the brain 
and pituitary6,8,24,25. In the cardiovascular system, CNP is expressed in endothelial cells, where it acts as 
a vascular mediator regulating local vascular tone and growth9,10,26,27. In ovarian maturation, the CNP/
GC-B system is essential for oocyte meiotic arrest and cumulus oophorus formation11–13,28–30. As for 
skeletal tissue, we had elucidated that the CNP/GC-B system directly stimulates endochondral bone 
growth in the growth plate; CNP stimulates tibial explants from fetal mice in organ culture31, and mice 
with targeted overexpression of CNP in the growth plate exhibit prominent skeletal overgrowth pheno-
type32. Indeed, CNP and GC-B exist in nonhypertrophic and prehypertrophic chondrocyte layers of the 
growth plate, respectively16. Together with the fact that mice with systemic depletion of CNP or GC-B 
exhibit severely impaired growth of bones formed through endochondral ossification, we could suppose 
that the local CNP/GC-B system in the growth plate is a physiological stimulator of endochondral bone 
growth. Nevertheless, it remains possible that the CNP/GC-B physiologically regulates endochondral 
bone growth via mechanisms other than the local effect on the growth plate; CNP secreted from a tis-
sue other than growth plate cartilage might influence or stimulate endochondral bone growth. In fact, 
CNP is capable of humorally stimulating endochondral bone growth, as demonstrated by the obser-
vation that transgenic mice with elevated plasma concentrations of CNP exhibit skeletal overgrowth 
phenotype20,33. Furthermore, in tissues other than growth-plate cartilage, the CNP/GC-B system may 
stimulate other regulatory systems that influence endochondral bone growth, e.g., the GH/IGF-I axis. In 
this study, however, we showed that the extent of impairment of endochondral bone growth observed in 
cartilage-specific CNP or GC-B knockout mice is almost the same as in systemic CNP or GC-B knockout 
mice, respectively. Thus, the autocrine/paracrine effect of the CNP/GC-B system in the growth plate is 
the primary physiological stimulator of endochondral bone growth in body.
In the present study, first we generated mice with cartilage-specific depletion of CNP, the ligand of the 
CNP/GC-B system (Col2a1-Cre; Nppcflox/flox mice). Next, to further confirm the local regulation of endo-
chondral bone growth by the system, we developed mice with cartilage-specific depletion of the receptor, 
GC-B (Col2a1-Cre; Npr2flox/flox mice). As the result, we could obtain qualitatively the same skeletal pheno-
type in Col2a1-Cre; Nppcflox/flox and Col2a1-Cre; Npr2flox/flox mice, strengthening the notion that the CNP/
GC-B system is the local stimulator of physiological endochondral bone growth. Nevertheless, impair-
ment of skeletal growth in Col2a1-Cre; Npr2flox/flox mice was more severe than in Col2a1-Cre; Nppcflox/flox 
mice. The most plausible reason for this discrepancy would be that in Col2a1-Cre; Nppcflox/flox mice, CNP 
secreted from tissues other than cartilage (e.g., blood vessels), could bind GC-B in the growth plates, 
resulting in a milder impairment of endochondral bone growth than in Col2a1-Cre; Npr2flox/flox mice. 
Furthermore, as the abundance of a ligand is greater than that of its receptor in general, the amount of 
the leaked ligand, CNP, in Col2a1-Cre; Nppcflox/flox mice might be greater than that of its receptor (GC-B) 
in Col2a1-Cre; Npr2flox/flox mice, so the leaking effect of the CNP/GC-B system on endochondral could be 
stronger in Col2a1-Cre; Nppcflox/flox mice than in Col2a1-Cre; Npr2flox/flox mice. In addition, this might be 
because in the absence of CNP, the sensitivity of GC-B may be increased or a clearance system of natriu-
retic peptide may be inactivated (e.g., through the down-regulation of the expression of C-receptor33, or 
by increasing the natural ligand of C-receptor, osteocrin34), and therefore GC-B may easily be activated 
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Figure 6. Impaired skeletal growth in Col2a1-Cre; Npr2flox/flox mice. (a) Soft x-ray picture and (b) graph 
of lengths of bones (skull length, skull width, humerus, radius, ulna, femur, tibia, and lumber) of Npr2flox/
flox and Col2a1-Cre; Npr2flox/flox mice at 10-week-old. *: P < 0.01, n = 5, each. (c)–(f) Histological analyses of 
tibial growth plates of Npr2flox/flox and Col2a1-Cre; Npr2flox/flox mice at the age of 2 weeks. Scale bar: 100 μ m in 
each panel. (c) Micrographs of growth plates stained by Alcian Blue-hematoxylin and eosin (left pictures), 
and the thickness of growth plates (right graph). *: P < 0.01, n = 5, each. In micrographs, right panel in each 
set of panels is exhibited with higher magnification. (d), (e) Pictures of tibial growth plate stained by type II 
(d) and X (e) collagen antibodies (upper panels), and the thickness of nonhypertrophic (d) and hypertrophic 
(e) chondrocyte layers of the growth plates (lower graphs). *: P < 0.01, n = 5, each. (f) Pictures of tibial 
growth plates with BrdU staining (left panels) and the proliferative rate of chondrocytes in growth plate 
shown as the average percent of BrdU-positive cells relative to the total cell count (right graph). *: P < 0.05, 
n = 5, each.
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by other natriuretic peptides, i.e., ANP or BNP. Actually, increased circulating BNP can crossreact with 
GC-B and stimulate endochondral bone growth in mice35,36.
Histological images revealed that among the chondrocyte layers of the growth plate, the hypertrophic 
chondrocyte layers were the most drastically reduced in both Col2a1-Cre; Nppcflox/flox and Col2a1-Cre; 
Npr2flox/flox mice. In situ hybridization analyses of Col2a1-Cre; Nppcflox/flox growth plate revealed the 
decreased areas of the gene expressions for chondrocyte differentiation markers and tendencies of 
decreased intensities of these gene expressions, especially that of Indian hedgehog, a key molecule for 
chondrocyte differentiation that plays an important role on the transition from prehypertrophic chon-
drocytes to hypertrophic chondrocytes. In addition, the height of the proliferative chondrocyte layer, 
along with the proliferation of chondrocytes in that region, was moderately reduced in both Col2a1-Cre; 
Nppcflox/flox and Col2a1-Cre; Npr2flox/flox growth plates. These data indicate that under physiological con-
ditions, the CNP/GC-B system in the growth plate mildly stimulates the proliferation of chondrocytes 
in the proliferative chondrocyte layer, and then potently promotes their hypertrophic differentiation; the 
promotion of the transitional differentiation from prehypertrophic chondrocytes to hypertrophic chon-
drocytes is thought to be the major contributing factor for the stimulatory effect of CNP/GC-B signaling 
on endochondral bone growth. As for the mechanism of the strong and physiological stimulatory effect 
of hypertrophic differentiation by the CNP/GC-B system, Kawasaki et al. exhibited that a downstream 
molecule of the CNP/GC-B system, cGMP dependent protein kinase (cGK) II37, promotes chondrocyte 
hypertrophy through phosphorylation of glycogen synthase kinase-3β and following decreased degrada-
tion of β -catenin38. This explanation sounds plausible, however, there still remains elusive problem that 
the narrowed growth plate of CNP or GC-B knockout is quite different from the extraordinary widened 
growth plate of cGKII knockout mice. Further studies must be necessary for the clarification of this 
point.
Previously, we reported that the survival rate of total CNP knockout mice is about 40%16. We hypoth-
esized that one reason for the early death of these mice after weaning is starvation caused by their severe 
malocclusion. Indeed, the survival rate of total CNP knockout mice increased to ~70% when they were 
supplied with pulverized feed. Likewise, the survival rate of Col2a1-Cre; Nppcflox/flox mice on pulverized 
feed (75.0%) is almost the same as that of total CNP knockout mice on pulverized feed. These data indi-
cate that the increased prevalence of early death in total CNP knockout mice is caused by their impaired 
skeletal growth. However, the mechanisms by which the impaired skeletal growth of these knockout mice 
increases their mortality (to ~30%) are still unknown. Further experiments to address this issue are now 
ongoing in our laboratory.
In conclusion, we have revealed that the CNP/GC-B system is responsible for physiological endo-
chondral bone growth via local action in cartilage, even though the CNP/GC-B system is ubiquitously 
present. Furthermore, this pathway might further affect mortality via unknown mechanisms.
Material and Methods
Ethics statement. Animal care and all experiments were conducted in accordance with the insti-
tutional guidelines of Kyoto University Graduate School of Medicine. All experimental protocols were 
approved by the institutional committee of Kyoto University Graduate School of Medicine.
Generation of Nppcflox mice and Npr2flox mice. The targeting vector contains two flippase recom-
bination target (FRT) sites that flank neomycin cassettes, and two loxP sites that flank exons 1 and 2 
of Nppc for Nppcflox mice or exons 3–7 of Npr2 for Npr2flox mice and neomycin cassettes (Fig.1a, 4a). 
Linearized targeting vector was transfected into embryonic stem (ES) cells. ES clones heterozygous for 
the Nppc-floxed or Npr2-floxed allele were identified by PCR screening and confirmed by Southern-blot 
analysis using an Nppc or Npr2 probe, respectively, located outside of the homology regions used for gene 
recombination. Mouse chimeras were generated by C57BL/6 host blastocyst injection of mutant ES-cell 
clones, and the resulting chimeras were bred with C57BL/6 mice to generate Nppc-floxed or Npr2-floxed 
heterozygous mice.
Generation of cartilage-specific Nppc knockout mice and cartilage-specific Npr2 knockout 
mice. In the first cross, Col2a1–Cre transgenic mice21,39 were mated with mice heterozygous for the 
Nppc-floxed or Npr2-floxed allele. Offspring inheriting the Col2a1–Cre and Nppc-floxed or Npr2-floxed 
alleles were then mated with Nppc-floxed or Npr2-floxed heterozygous mice to obtain embryos harboring 
the Col2a1–Cre transgene along with two Nppc-floxed or Npr2-floxed alleles. Routine mouse genotyping was 
performed by PCR. The following primer pairs were used: Cre, 5′ -TCCAATTTACTGACCGTACACCAA
-3′ and 5′ -CCTGATCCTGGCAATTTCGGCTA3′ ; Nppc floxdel allele, 
5′ -GTGTCCACAGTGAGTTCTTTACCAG-3′ and 5′ -GTAAAGTGTGTCTCATCATCACATCATC
-3′ ; and Npr2 floxdel allele, 5′ -GTAACCTGGGTAGACTAGTTGTTGG-3′ and 
5′ -ATGGTGGAGGAGGTCTTTAATTCC-3.
There was not any gender difference in the results of this study, so we presented the results of exper-
iments using male mice only as the representative.
Quantification of the gene expressions for Nppc and Npr2. For quantification of the gene 
expressions for Nppc and Npr2, real-time RT-PCR was performed in a StepOne™ real-time PCR System 
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(Applied Biosystems). Complementary DNA was mixed with TaqMan® Universal PCR Master Mix 
(Applied Biosystems) and TaqMan® Gene Expression Assay primers (Applied Biosystems): natriuretic 
peptide receptor 2 (Mm00612889_m1), natriuretic peptide type C (Mm01295410_m1), and GAPDH 
(Mm99999915_g1). All RNA samples were titrated to yield equal amplification of GAPDH as an internal 
normalization control. Reactions for each sample were performed in triplicate. After an initial denatura-
tion step (95 °C for 10 min), amplification was performed for 45 cycles (15-second denaturation at 95 °C 
and 60-second extension at 60 °C).
Skeletal analysis. Skeletal analysis was performed as previously described32. Briefly, mice were sub-
jected to soft x-ray analysis (30 kVp, 5 mA for 1 min; Softron Type SRO-M5; Softron, Tokyo, Japan), and 
the lengths of the bones were measured on the soft x-ray film. Naso-tail and naso-anal length measure-
ments were made every week.
Histological analysis. For light microscopy, sections were cut from paraffin-embedded specimens. 
For Alcian Blue-hematoxylin and eosin staining, sections were deparaffinized with xylene and rehydrated 
through an ethanol series and distilled water. The sections were treated with 3% acetic acid for 3 min, 
and with Alcian Blue (Muto Pure Chemicals Co., Ltd., Tokyo, Japan) for 20 min. Next, they were treated 
with hematoxylin (Muto) for 2 min, eosin alcohol (Muto) for 1 min, dehydrated, and then mounted with 
malinol (Muto).
For immunohistochemical detection of CNP, GC-B, type II collagen, and type X collagen, tissue sec-
tions were incubated with monoclonal anti-CNP antibody (T-4223, Peninsula Laboratories, CA, USA), 
anti-GC-B antibody (sc-16870, Santa Cruz Biotechnology, Santa Cruz, CA, USA), type II collagen anti-
body (1320-01, Southern Biotech, AL, USA), or type X collagen antibody (LB-0092, LSL, Japan), and 
immunostaining was performed using the Histofine MOUSESTAIN kit (Nichirei Corp., Tokyo, Japan) 
according to the manufacturer’s instructions.
In situ hybridization analyses were performed as previously described in Reference 20.
BrdU analysis of growth plates. BrdU (5-Bromo-2′ -deoxyuridine, 05650, Nacalai, Kyoto, Japan) 
was injected intraperitoneally at a concentration of 50 |g/g body weight 2 h before sacrifice. Target skele-
tal tissues were harvested, fixed overnight at 4 °C in a 4% paraformaldehyde solution, and then decalcified 
for 2 weeks in 0.5 M EDTA. Decalcified samples were embedded in paraffin and sectioned. BrdU-positive 
cells were detected using a BrdU antibody. The number of BrdU-positive nuclei, as a percentage of the 
total number of nuclei, was defined as the proliferation index.
Genotype-specific survival. Generation of total CNP knockout mice (Nppc−/− mice) was previ-
ously reported16. After weaning, Nppc−/− mice were divided into one group that was provided with 
solid feed and another group that was provided with pulverized feed. Col2a1–Cre; Nppcflox/flox mice were 
all provided with pulverized feed. Differences in survival rates between genotypes were assessed using 
Kaplan-Meier analysis.
Statistical analysis. Data are expressed as means ± SEM. Statistical analysis was performed using 
ANOVA with Fisher’s least-significant-difference method when appropriate. P values less than 0.05 were 
considered statistically significant.
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